Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J G Frelinger

Showing results (61-70 of 63) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 63 results.
Human Gene Therapy|October 9, 2001
Dendritic cells transduced with HSV-1 amplicons expressing prostate-specific antigen generate antitumor immunity in miceR A Willis, W J Bowers, M J Turner, et al.
Cancer Immunology, Immunotherapy : CII|July 1, 1996
Expression of human prostate-specific antigen (PSA) in a mouse tumor cell line reduces tumorigenicity and elicits PSA-specific cytotoxic T lymphocytesC Wei, E Storozynsky, A J McAdam, et al.
Nature Communications|June 26, 2015
Non-redundant requirement for CXCR3 signalling during tumoricidal T-cell trafficking across tumour vascular checkpointsM E Mikucki, D T Fisher, J Matsuzaki, et al.
Pageof 7

Showing results (61-70 of 63) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 63 results.
Human Gene Therapy|October 9, 2001
Dendritic cells transduced with HSV-1 amplicons expressing prostate-specific antigen generate antitumor immunity in miceR A Willis, W J Bowers, M J Turner, et al.
Cancer Immunology, Immunotherapy : CII|July 1, 1996
Expression of human prostate-specific antigen (PSA) in a mouse tumor cell line reduces tumorigenicity and elicits PSA-specific cytotoxic T lymphocytesC Wei, E Storozynsky, A J McAdam, et al.
Nature Communications|June 26, 2015
Non-redundant requirement for CXCR3 signalling during tumoricidal T-cell trafficking across tumour vascular checkpointsM E Mikucki, D T Fisher, J Matsuzaki, et al.
Pageof 7